<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ceja L</submitter><funding>California Institute for Regenerative Medicine</funding><pagination>8088</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10179407</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(9)</volume><pubmed_abstract>New stem cell and extracellular-vesicle-based therapies have the potential to improve outcomes for the increasing number of patients with heart failure. Since neonates have a significantly enhanced regenerative ability, we hypothesized that extracellular vesicles isolated from Islet-1+ expressing neonatal human cardiovascular progenitors (CPCs) will induce transcriptomic changes associated with improved regenerative capability when co-cultured with CPCs derived from adult humans. In order to test this hypothesis, we isolated extracellular vesicles from human neonatal Islet-1+ CPCs, analyzed the extracellular vesicle content using RNAseq, and treated adult CPCs with extracellular vesicles derived from neonatal CPCs to assess their functional effect. AKT, ERBB, and YAP1 transcripts were elev</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Neonatal Cardiovascular-Progenitor-Cell-Derived Extracellular Vesicles Activate YAP1 in Adult Cardiac Progenitor Cells.</pubmed_title><pmcid>PMC10179407</pmcid><funding_grant_id>EDUC2-08418</funding_grant_id><pubmed_authors>Ceja L</pubmed_authors><pubmed_authors>Hughes L</pubmed_authors><pubmed_authors>Camberos V</pubmed_authors><pubmed_authors>Vallejos P</pubmed_authors><pubmed_authors>Lopez LV</pubmed_authors><pubmed_authors>Wall NR</pubmed_authors><pubmed_authors>Kearns-Jonker M</pubmed_authors><pubmed_authors>Escopete SS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neonatal Cardiovascular-Progenitor-Cell-Derived Extracellular Vesicles Activate YAP1 in Adult Cardiac Progenitor Cells.</name><description>New stem cell and extracellular-vesicle-based therapies have the potential to improve outcomes for the increasing number of patients with heart failure. Since neonates have a significantly enhanced regenerative ability, we hypothesized that extracellular vesicles isolated from Islet-1+ expressing neonatal human cardiovascular progenitors (CPCs) will induce transcriptomic changes associated with improved regenerative capability when co-cultured with CPCs derived from adult humans. In order to test this hypothesis, we isolated extracellular vesicles from human neonatal Islet-1+ CPCs, analyzed the extracellular vesicle content using RNAseq, and treated adult CPCs with extracellular vesicles derived from neonatal CPCs to assess their functional effect. AKT, ERBB, and YAP1 transcripts were elev</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-21T22:46:00.831Z</modification><creation>2025-04-05T18:51:41.542Z</creation></dates><accession>S-EPMC10179407</accession><cross_references><pubmed>37175796</pubmed><doi>10.3390/ijms24098088</doi></cross_references></HashMap>